Standard Biotools (LAB) Acquisitions (2014 - 2024)
Standard Biotools (LAB) reported Acquisitions of -$278.6 million for Q4 2024, down 199.51% on a QoQ basis from $280.0 million in Q1 2024.
Standard Biotools (LAB) has 3 years of Acquisitions data on file, last reported at -$278.6 million in Q4 2024.
- Quarterly Acquisitions changed N/A year-over-year to -$278.6 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.4 million (changed N/A YoY) and the FY2024 annual result came in at $1.4 million, changed N/A from the prior year.
- Acquisitions fell to -$278.6 million in Q4 2024 per LAB's latest filing, from $280.0 million in the prior quarter.
- Across five years, Acquisitions topped out at $280.0 million in Q1 2024 and bottomed at -$278.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 523.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -268.10 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.30 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -278.65 Mn |
| Mar 31, 2024 | 280.03 Mn |
| Mar 31, 2020 | 5.15 Mn |
| Mar 31, 2014 | 113.19 Mn |